BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2018

Type / Class
Debt / NOTE 0.750%10/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.750%10/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2018 Q4 $0 $0 -$362,053,297 0
2018 Q3 $350,274,000 $362,052,099 +$17,703,864 103.46% 35
2018 Q2 $330,463,000 $351,061,548 -$2,959,384 106.11% 48
2018 Q1 $333,743,000 $342,378,063 -$19,490,677 102.47% 43
2017 Q4 $338,755,000 $367,571,182 -$11,587,554 108.18% 42
2017 Q3 $348,838,000 $389,828,244 +$10,077,647 111.56% 43
2017 Q2 $340,031,200 $380,830,000 -$2,409,137 110.83% 47
2017 Q1 $340,484,200 $386,409,638 -$7,779,379 113.35% 41
2016 Q4 $354,439,200 $404,099,000 -$18,499,909 112.48% 40
2016 Q3 $374,476,000 $449,657,000 -$2,656,918 119.95% 43
2016 Q2 $351,282,002 $390,766,002 -$3,111,124 111.1% 44
2016 Q1 $378,910,533 $438,219,000 +$12,225,572 115.76% 48
2015 Q4 $367,076,000 $472,735,000 -$7,642,414 128.5% 42
2015 Q3 $363,935,000 $473,515,000 -$1,588,875 129.44% 53
2015 Q2 $359,575,832 $557,009,293 +$70,479,216 154.13% 53
2015 Q1 $311,455,000 $462,822,000 +$55,099,014 148.8% 50
2014 Q4 $276,560,709 $326,738,837 -$49,629,285 117.86% 45
2014 Q3 $323,889,000 $344,206,000 +$3,548,852 105.88% 45
2014 Q2 $320,654,000 $333,253,000 +$53,183,855 103.44% 43
2014 Q1 $240,454,000 $263,492,000 -$17,153,209 109.57% 33